The effect of diagnostic assessment programs on the diagnosis and treatment of patients with lung cancer in Ontario, Canada.
Diagnostic assessment program
efficiency
guideline concordance
imaging
lung cancer
wait times
Journal
Annals of thoracic medicine
ISSN: 1817-1737
Titre abrégé: Ann Thorac Med
Pays: India
ID NLM: 101280721
Informations de publication
Date de publication:
Historique:
received:
21
05
2020
accepted:
26
08
2020
entrez:
8
3
2021
pubmed:
9
3
2021
medline:
9
3
2021
Statut:
ppublish
Résumé
Diagnostic assessment programs (DAPs) were implemented in Ontario, Canada, to improve the efficiency of the lung cancer care continuum. We compared the efficiency and effectiveness of care provided to patients in DAPs relative to usual care (non-DAPs). Lung cancer patients diagnosed between 2014 and 2016 were identified from the Ontario Cancer Registry. Using administrative databases, we identified various health-care encounters 6 months before diagnosis until the start of treatment and compared utilization patterns, timing, and overall survival between DAP and non-DAP patients. DAP patients were younger ( DAPs provided earlier treatment and better access to care, potentially improving survival. Quality improvement opportunities include reducing unnecessary or duplicate testing and characterizing patients who are diagnosed emergently.
Identifiants
pubmed: 33680129
doi: 10.4103/atm.ATM_283_20
pii: ATM-16-81
pmc: PMC7908893
doi:
Types de publication
Journal Article
Langues
eng
Pagination
81-101Informations de copyright
Copyright: © 2021 Annals of Thoracic Medicine.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
BMJ Open. 2017 Feb 23;7(2):e013965
pubmed: 28235969
J Med Imaging Radiat Oncol. 2018 Jun;62(3):383-388
pubmed: 29745036
Eur Respir J Suppl. 2002 Feb;35:40s-48s
pubmed: 12064680
Ann Intern Med. 2009 Aug 18;151(4):221-8, W-48
pubmed: 19581636
J Trauma Acute Care Surg. 2013 Mar;74(3):813-7
pubmed: 23425740
Br J Cancer. 2012 Oct 9;107(8):1220-6
pubmed: 22996611
Can Assoc Radiol J. 2015 Feb;66(1):53-7
pubmed: 24931045
Lancet. 2011 Jan 8;377(9760):127-38
pubmed: 21183212
Thorax. 2009 Sep;64(9):749-56
pubmed: 19717709
Cancer Manag Res. 2018 Dec 20;11:107-115
pubmed: 30588114
Chest. 2016 Apr;149(4):943-50
pubmed: 26356134
Eur Respir Rev. 2018 Aug 29;27(149):
pubmed: 30158277
CMAJ Open. 2019 Feb 25;7(1):E117-E123
pubmed: 30808631
Nucl Med Commun. 2017 Jan;38(1):99-100
pubmed: 27898648
Aust Health Rev. 2016 Jan;40(6):649-654
pubmed: 26909516
Eur J Oncol Nurs. 2018 Jun;34:82-88
pubmed: 29784144
Med Care. 2010 Jun;48(6 Suppl):S114-20
pubmed: 20473199
Int J Clin Oncol. 2018 Aug;23(4):641-646
pubmed: 29484515
Curr Oncol. 2017 Oct;24(5):302-309
pubmed: 29089797
Lung Cancer. 2017 Oct;112:156-164
pubmed: 29191588
J Thorac Oncol. 2007 Nov;2(11):1001-6
pubmed: 17975490
Med Care. 2005 Nov;43(11):1130-9
pubmed: 16224307
PLoS One. 2018 Aug 22;13(8):e0201288
pubmed: 30133466
Clin Lung Cancer. 2017 Nov;18(6):e403-e409
pubmed: 28571689
J Thorac Oncol. 2013 Jul;8(7):876-82
pubmed: 23575416
J Thorac Dis. 2018 Jul;10(Suppl 18):S2168-S2171
pubmed: 30123551
Medicine (Baltimore). 2015 Jul;94(29):e1216
pubmed: 26200646
BMJ Open. 2019 Nov 27;9(11):e025895
pubmed: 31776134